【摘要】：正血友病的治療開始于19世紀(jì)40年代,最初僅為鮮血的直接輸注。20世紀(jì)50至60年代,新鮮冰凍血漿及冷沉淀相繼應(yīng)用于臨床。隨后隨著技術(shù)進(jìn)步,凝血因子Ⅷ(FⅧ)和凝血因子Ⅸ(FⅨ)濃縮制劑陸續(xù)出現(xiàn),該制劑使血友病家庭治療成為可能,極大改善了血友病患者的生活質(zhì)量[1]。但不幸的是,20世紀(jì)70至80年代,由于血源性替代產(chǎn)品的應(yīng)用,世界范圍內(nèi)數(shù)千例血友病患者感染了人類免疫缺陷病毒(HIV)和丙型肝炎病毒
[Abstract]:The treatment of positive hemophilia began in the 1840s and was initially a direct transfusion of blood. In the 1950s and 1960s, fresh frozen plasma and cryoprecipitation were used in clinical practice. Subsequently, with the development of technology, clotting factor 鈪，

本文編號：2202049